Brooks Laboratories Ltd (BROOKS)
₹90.12▲6.42%
Performance
Day's Low
Day's High
₹85.48₹9252 Week's Low
52 Week's High
₹73.25₹185.7
| Returns % | |
| 1 Month Return | -2.71 % |
| 3 Month Return | -19.2 % |
| 1 Year Return | -0.82 % |
| Market Stats | |
| Previous Close | ₹84.68 |
| Open | ₹85.50 |
| Volume | 1.60L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹222.26Cr |
Key Statistics
| P/E Ratio | -10.98 |
| PEG Ratio | -3.72 |
| Market Cap | ₹222.26 Cr |
| P/B Ratio | 2.72 |
| EPS | -7.74456790857052 |
Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹222.26 Cr | 31.71% | 0.57 | -₹32 Cr | ₹63 Cr |
 | NA | ₹17.18 Cr | -6.84% | 0.50 | -₹3 Cr | ₹45 Cr |
| NA | ₹164.28 Cr | 90.19% | 0.58 | NA | NA |
 | NA | ₹1,131.02 Cr | 120.9% | 0.54 | ₹27 Cr | ₹550 Cr |
| NA | ₹14.76 Cr | 80.9% | 0.69 | NA | NA |
Mutual Fund Holdings
| Funds | Holdings | Prev. 6M |
|---|---|---|
 Quant Business Cycle Fund Direct Growth | 0.34% | |
| Quant Healthcare Fund Direct Growth | 1.39% |
Company Information
Brooks Laboratories Ltd was established in January 2002 and it started operations and commercial production in May and June 2006 respectively. It obtained an ISO 9001:2008 Certificate in August 2007 and an Import License from Drugs Controller General of India in October 2006. On August 2011, they raised Rs. 63 crore through IPO and their shares officially listed on stock exchanges in September 2011.
Their current manufacturing facility at Baddi is 100% operational, with world class dedicated carbapenem facility in Vadodara Plant which commenced activity on 7 March 2017. Baddi facility was upgraded in June 2017 for 3 months, and production in injectable line resumed from September onwards. Finally, production commenced in August 2017 in the renovated building and was almost double than the previous line.
Share Price: ₹90.12 per share as on 24 Jul, 2024 04:01 PM
Market Capitalisation: ₹222.26Cr as of today
Revenue: ₹17.72Cr as on March 2024 (Q1 24)
Net Profit: ₹-9.61Cr as on March 2024 (Q1 24)
Listing date: 05 Sep, 2011
| Organisation | Brooks Laboratories Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Insights on Brooks Laboratories Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 63.59% of holdings in Jun 2024 quarter
- NO EFFECT
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 32.55% of holdings in Jun 2024 quarter
- NO EFFECT
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 127.7% return, outperforming this stock by 132.8%
- NO EFFECT
Against Peers
In the last 1 year, Zydus Lifesciences Ltd has given 87.2% return, outperforming this stock by 88.0%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 3 quarters, 24.41 Cr → 18.38 Cr (in ₹), with an average decrease of 13.2% per quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, -1.64 Cr → -9.61 Cr (in ₹), with an average decrease of 142.1% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 3 months, BROOKS stock has moved down by -19.2%
Company Financials
| Q'1 24 | Q/Q Change | |
|---|---|---|
Revenue | ₹17.72Cr | ↓18.53% |
Net Income | -₹9.61Cr | ↑147.68% |
Net Profit Margin | -54.23% | ↑203.98% |
| 2023 | Y/Y Change | |
|---|---|---|
Revenue | ₹63.20Cr | ↓30.69% |
Net Income | -₹31.05Cr | ↑60.80% |
Net Profit Margin | -49.13% | ↑131.96% |
| 2023 | Y/Y Change | |
|---|---|---|
Total Assets | ₹92.43Cr | ↓10.65% |
Total Liabilities | ₹35.65Cr | ↓7.28% |
| 2023 | Y/Y Change | |
|---|---|---|
Operating Cash Flow | ₹0.56Cr | ↓82.05% |
Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 63.59% | 0.00 | |
| Foreign Institutions | 0% | ||
| Mutual Funds | 3.86% | 0.00 | |
| Retail Investors | 32.55% | 0.00 | |
| Others | 0% |
Key Indicators
Brooks Laboratories Ltd Valuation
Brooks Laboratories Ltd in the last 5 years
Lowest (-31.14x)
January 11, 2024
Today (-10.98x)
July 23, 2024
Industry (56.07x)
July 23, 2024
Highest (-5.43x)
May 25, 2023
Earnings and Dividends
Brooks Laboratories Ltd Earnings Results
Brooks Laboratories Ltd’s net profit fell -124.01% since last year same period to ₹-9.61Cr in the Q4 2023-2024. On a quarterly growth basis, Brooks Laboratories Ltd has generated -147.68% fall in its net profits since last 3-months.
Read More about Earnings Results
Technicals Summary
Bearish
Neutral
Bullish
Brooks Laboratories Ltd is currently in a Bullish trading position according to technical analysis indicators.
Frequently Asked Questions
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Brooks Laboratories Ltd shares.
Brooks Laboratories Ltd (BROOKS) share price today is ₹90.12
Brooks Laboratories Ltd is listed on NSE
Brooks Laboratories Ltd is listed on BSE
- Today’s highest price of Brooks Laboratories Ltd is ₹92.
- Today’s lowest price of Brooks Laboratories Ltd is ₹85.48.
PE Ratio of Brooks Laboratories Ltd is -10.98
PE ratio = Brooks Laboratories Ltd Market price per share / Brooks Laboratories Ltd Earnings per share
Today’s traded volume of Brooks Laboratories Ltd(BROOKS) is 1.60L.
Today’s market capitalisation of Brooks Laboratories Ltd(BROOKS) is ₹222.26Cr.
| Brooks Laboratories Ltd(BROOKS | Price |
|---|---|
52 Week High | ₹185.7 |
52 Week Low | ₹73.25 |
Brooks Laboratories Ltd(BROOKS) share price is ₹90.12. It is down -51.47% from its 52 Week High price of ₹185.7
Brooks Laboratories Ltd(BROOKS) share price is ₹90.12. It is up 23.03% from its 52 Week Low price of ₹73.25
| Brooks Laboratories Ltd(BROOKS | Returns |
|---|---|
1 Day Returns | 5.44% |
1 Month Returns | -2.71% |
3 Month Returns | -19.2% |
1 Year Returns | -0.82% |